These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 6389091
1. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam]. Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC. Encephale; 1984; 10(3):135-8. PubMed ID: 6389091 [Abstract] [Full Text] [Related]
2. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E. J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097 [Abstract] [Full Text] [Related]
3. [Value of prazepam drops in the brief treatment of anxiety disorders]. Ansseau M, Von Frenckell R. Encephale; 1991 Dec; 17(4):291-4. PubMed ID: 1959497 [Abstract] [Full Text] [Related]
4. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety. Dorman T. Pharmatherapeutica; 1983 Dec; 3(6):433-40. PubMed ID: 6353434 [Abstract] [Full Text] [Related]
5. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety. Pinosky DG. J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763 [Abstract] [Full Text] [Related]
6. [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety]. Guelfi JD, Lancrenon S, Millet V. Encephale; 1993 Oct; 19(5):547-52. PubMed ID: 8306923 [Abstract] [Full Text] [Related]
12. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety]. Lôo H, Malka R, Hantouche E, Lancrenon S, Guelfi JD. Encephale; 1991 Dec 14; 17(4):295-300. PubMed ID: 1959498 [Abstract] [Full Text] [Related]
13. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology. Finkel S. J Clin Psychiatry; 1978 Oct 14; 39(10 Pt 2):35-40. PubMed ID: 30766 [Abstract] [Full Text] [Related]
14. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial. Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK. Psychopharmacol Bull; 1993 Oct 14; 29(2):303-8. PubMed ID: 7904761 [Abstract] [Full Text] [Related]
15. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. Cohn JB, Wilcox CS. J Clin Psychiatry; 1986 Aug 14; 47(8):409-12. PubMed ID: 2874128 [Abstract] [Full Text] [Related]
16. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology. Berkowitz JM. J Clin Psychiatry; 1978 Oct 14; 39(10 Pt 2):46-52. PubMed ID: 30768 [Abstract] [Full Text] [Related]
17. The effect of lorazepam on hypertension-associated anxiety: a double-blind study. Hart WL, Parmley LF. J Clin Psychiatry; 1978 Oct 14; 39(10 Pt 2):41-5. PubMed ID: 30767 [Abstract] [Full Text] [Related]
18. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety]. Samuelian JC, Billardon M, Guillou N. Encephale; 1995 Oct 14; 21(2):147-53. PubMed ID: 7781586 [Abstract] [Full Text] [Related]
19. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern ME, Micallef J, Blin O. Hum Psychopharmacol; 2006 Apr 14; 21(3):139-49. PubMed ID: 16625522 [Abstract] [Full Text] [Related]
20. [Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care]. Chabannes JP, Lemoine P. Therapie; 1990 Apr 14; 45(6):467-70. PubMed ID: 2080484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]